|
Volumn 26, Issue 4, 2000, Pages 210-215
|
Utilization of generic drugs in Spain and Catalonia: Possibilities of savings;Implantacion de medicamentos genericos (EFG) en Espana y Cataluna: Posibilidades de ahorro
|
Author keywords
Cost savings; Drug utilization; Generic drugs
|
Indexed keywords
GENERIC DRUG;
ACICLOVIR;
ALLOPURINOL;
ALPRAZOLAM;
AMBROXOL;
AMOXICILLIN;
ANTIBIOTIC AGENT;
ANTIDEPRESSANT AGENT;
ANTIVIRUS AGENT;
ATENOLOL;
CAPTOPRIL;
CARBAMAZEPINE;
CIPROFLOXACIN;
DICLOFENAC;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
FAMOTIDINE;
FLUOXETINE;
GEMFIBROZIL;
HISTAMINE H2 RECEPTOR ANTAGONIST;
NAPROXEN;
NIFEDIPINE;
NONSTEROID ANTIINFLAMMATORY AGENT;
NORFLOXACIN;
PIROXICAM;
RANITIDINE;
SEROTONIN UPTAKE INHIBITOR;
TAMOXIFEN;
TICLOPIDINE;
TRAMADOL;
UNINDEXED DRUG;
ARTICLE;
COMPARATIVE STUDY;
COST CONTROL;
CROSSOVER PROCEDURE;
ECONOMICS;
PRESCRIPTION;
PUBLIC HEALTH;
SPAIN;
THEORETICAL MODEL;
DRUG COST;
DRUG USE;
HUMAN;
MAJOR CLINICAL STUDY;
PSYCHOPHARMACOTHERAPY;
COST SAVINGS;
CROSS-OVER STUDIES;
DRUGS, GENERIC;
MODELS, THEORETICAL;
PRESCRIPTIONS, DRUG;
PUBLIC HEALTH;
SPAIN;
|
EID: 0033787556
PISSN: 02126567
EISSN: None
Source Type: Journal
DOI: 10.1016/S0212-6567(00)78649-5 Document Type: Article |
Times cited : (9)
|
References (27)
|